AbCellera Biologics Inc. revenue breakdown overview

AbCellera Biologics Inc. revenue for the last year amounted to 38.02 M USD, the most of which — 38.02 M USD — came from its highest performing source at the moment, Antibodies, the year earlier bringing 485.42 M USD. The greatest contribution to the revenue figure was made by Canada — last year it brought AbCellera Biologics Inc. 36.00 M USD, and the year before that — 484.20 M USD.